On the use of discrete choice models for causal inference

Methodology for causal inference based on propensity scores has been developed and popularized in the last two decades. However, the majority of the methodology has concentrated on binary treatments. Only recently have these methods been extended to settings with multi-valued treatments. We propose a number of discrete choice models for estimating the propensity scores. The models differ in terms of flexibility with respect to potential correlation between treatments, and, in turn, the accuracy of the estimated propensity scores. We present the effects of discrete choice models used on performance of the causal estimators through a Monte Carlo study. We also illustrate the use of discrete choice models to estimate the effect of antipsychotic drug use on the risk of diabetes in a cohort of adults with schizophrenia.

[1]  M. Heo,et al.  Antipsychotic-induced weight gain: a comprehensive research synthesis. , 1999, The American journal of psychiatry.

[2]  Stephan Arndt,et al.  Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach. , 2001, Archives of general psychiatry.

[3]  P. Schmidt,et al.  Limited-Dependent and Qualitative Variables in Econometrics. , 1984 .

[4]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .

[5]  G. Maddala Limited-dependent and qualitative variables in econometrics: Introduction , 1983 .

[6]  P. Rosenbaum,et al.  Invited commentary: propensity scores. , 1999, American journal of epidemiology.

[7]  M. Weeks The Multinomial Probit Model Revisited: A Discussion of Parameter Estimability, Identification and Specification Testing , 1997 .

[8]  P. Rosenbaum The Consequences of Adjustment for a Concomitant Variable that Has Been Affected by the Treatment , 1984 .

[9]  D. Horvitz,et al.  A Generalization of Sampling Without Replacement from a Finite Universe , 1952 .

[10]  Paul R. Rosenbaum,et al.  Comparison of Multivariate Matching Methods: Structures, Distances, and Algorithms , 1993 .

[11]  C. Korenyi,et al.  Chlorpromazine induced diabetes. , 1968, Diseases of the nervous system.

[12]  G. Imbens The Role of the Propensity Score in Estimating Dose-Response Functions , 1999 .

[13]  R. D'Agostino Adjustment Methods: Propensity Score Methods for Bias Reduction in the Comparison of a Treatment to a Non‐Randomized Control Group , 2005 .

[14]  B. Sheitman,et al.  Olanzapine-induced elevation of plasma triglyceride levels. , 1999, The American journal of psychiatry.

[15]  Elaine L. Zanutto,et al.  Matching With Doses in an Observational Study of a Media Campaign Against Drug Abuse , 2001, Journal of the American Statistical Association.

[16]  Paul R. Rosenbaum,et al.  Balanced Risk Set Matching , 2001 .

[17]  J. Geweke,et al.  Alternative computational approaches to inference in the multinomial probit model , 1994 .

[18]  M. Lechner Identification and Estimation of Causal Effects of Multiple Treatments Under the Conditional Independence Assumption , 1999, SSRN Electronic Journal.

[19]  D. Rubin Randomization Analysis of Experimental Data: The Fisher Randomization Test Comment , 1980 .

[20]  S. Marder,et al.  Novel antipsychotics: comparison of weight gain liabilities. , 1999, The Journal of clinical psychiatry.

[21]  G. L’italien,et al.  An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients. , 2002, Archives of general psychiatry.

[22]  Robert Rosenheck,et al.  Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. , 2002, The American journal of psychiatry.

[23]  D. Basu Randomization Analysis of Experimental Data: The Fisher Randomization Test , 1980 .

[24]  J. Lindenmayer,et al.  Olanzapine-induced ketoacidosis with diabetes mellitus. , 1999, The American journal of psychiatry.